Intellectual Property Forum The Intellectual Property Forum

Please login or register.

Login with username, password and session length
Advanced search  

News:

New registrations are now permitted.

Show Posts

This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.

Messages - lacerda70

Pages: [1] 2 3 4 5
1
Patent Filing and Prosecution / Provisional Rights
« on: 02-29-12 at 11:07 am »
35 USC 154(d) states that provisional rights are available under 154(d) for issued patent claims which are substantially identical to claims in a "publication of the application for such patent" so long as several conditions are met (e.g. actual notice).

What about the case where the relevant claim issues in a continuation or divisional application and is substantially identical to a claim in the published parent application? In other words, can the the relevant claim be in an earlier published application that is an ancestor of the application that issued with the relevant claim?

The statute would seem to preclude that possibility, but I've seen several journal articles suggesting that the period can begin from publicaiton of an ancentor application and several recent complaints have used this approach.

I haven't found any relevant legal authority though.  Thoughts?

2
I presume the latter dates are Jan and Feb 2012 (not 2011).  At any rate, I don't see a problem:

Neither the PPA nor the 1st PCT will publish so they won't have any prior art effect.

The (presumably common) subject matter of these applications was first filed on 10-12-10 in the PPA and the 2nd PCT was filed past the one year date, so the priority date of the 2nd PCT will be 2-11-12. You won't be able to claim priority from the 1st PCT (for subject matter common to the PPA at least) because the conditions of Article 4(C)(4) are not met (i.e. PPA was not expired at time 1st PCT was filed and presumably the PPA was used as the basis of a priority claim in the 1st PCT)

You also won't be able to use the new PCT application as the basis for Paris convention priority for any future filed applications so if you're planning to file in any non-PCT countries, I would suggest doing that now.

Otherwise, I don't see any problem here.


3
Thanks all for the responses - great stuff here.

At the end of the day, I think NJ Patent 1's most recent post summarizes the situation quite well.

I'll post here if any clarifying case law/etc. turns up.

4
Isaac, so is it your position that the overlapping inventorship requirement of 120 is met in the case where a continuation is filed with claims having no inventors in common with the claims filed with the parent application?

In other words, does the overlapping inventor requirement of 120 refer to the subject matter disclosed in the parent and not the claims??  If this is the case, there would never be a situation where you wouldn't have overlapping inventors since the specifications are by definition the same.

On the other hand, if it applies to the claims (which it seems to me must be the case, since the inventorship is determined by what is claimed, not what is disclosed), then a continuation filed with claims having no inventors in common with the claims filed with the parent would not satisfy 120.  Which brings me back to my original point.

What exactly is the purpose of the overlapping inventor requirement anway?

5
Hey, I WANT you guys to be right, but have to consider how an opponent would argue.

What's odd to me about this situation is nobody I have talked to has actually run into it and I wish I could find just one statement somewhere (case law, MPEP, etc) other than 120 itself.

Consider the following 2 scenarios:
(1) continuation is filed with claims 1-10 of the parent and subsequently claims 1-10 are canceled and replaced by claim 11, the inventor of which is not an inventor of claims 1-10, thereby requiring deletion of all inventors under 1.48(b) and addition of new inventor under 1.48(c) (i.e. my original scenario); and
(2) continuation is filed with claim 11 and declaration lists only new inventor

In each case, the claim being pursued in each continuation is the same and there is ultimately no overlap of inventorship between the continuation and the parent; however, in the first case, but not the second, inventorship overlap was present at the time of filing.

bardencj - your reasoning would suggest that the second scenario should be fine because this is simply an example of the continuation claiming subject matter that was disclosed but not claimed in the parent.

But it doesn't seem like the second scenario would allow priority to the first since no inventorship overlap was present at the time of filing.  Indeed, the statement that "The grant or denial of a request under 37 CFR 1.48(a) may result in the lack of inventorship overlap between a parent application and a continuing application and the consequent inability to claim benefit in the continuing application of the parent application's filing date under 35 USC 120" certainly indicates that you can lose 120 priority to the parent application if no inventor overlap was present upon filing the continuation. 

Seems odd, no?

6
Isaac,

I'm not sure it's as clear as you're making it out to be.  You seem to be relying entirely on your interpretation of the words of 120.

Obviously the statement refering to 37 CFR 1.48(a) would not necessarily result in lack of inventor overlap, but the fact that it MAY result in lack of inventor overlap and therefore ability to claim priority, certainly indicates that such a scenario is possible.  This would be the case where the granting of a petition under 1.48(a) in a continuation removes all the common inventors with the parent application. 

I'm not sure why the case would be any different if you file a request under 1.48(b)/(c) in a continuation which (1) removes all common inventors with the parent and (2) adds new inventors none of whom is also listed on the parent.  In such a case, you now have oaths in the parent and the continuation with NO COMMON INVENTORS.

One thing that might support your position is that 37 CFR 1.48(a) is essentially correcting the inventorship of the originally filed declaration whereas in the 1.48(b)/(c) scenario the declaration was correct when filing but the inventors have changed due to amendment.

I can say that I've discussed this with several experienced prosecutors and none of them are as sure as you seem to be and most lean towards it not being acceptable.

7
NJ Patent 1 - Exactly!  In such a case, you would have a parent and a continuation, each with an oath having not one inventor in common with the other since a new oath/declaration would have to be filed in the continuation to add the new inventor(s).  How can this possibly satisfy 120???

8
Isaac, is there any authority to support that notion?

MPEP 201.03 (2.14.01) states that "The grant or denial of a request under 37 CFR 1.48(a) may result in the lack of inventorship overlap between a parent application and a continuing application and the consequent inability to claim benefit in the continuing application of the parent application's filing date under 35 USC 120."  This statement refers to 37 CFR 1.48(a), not 1.48(b) but could this apply to 1.48(b)/(c) as well (i.e., where you've removed all previous inventors under (b) and added new ones under (c))?

The only support I can find for what you state is the specific example in the MPEP of the case where an original parent application lists e.g. inventors A and B, where inventor A contributed only to invention 1 and inventor B contributed only to invention 2.  A restriction requirement is made and invention 1 is elected requiring inventor B to be deleted under 37 CFR 1.48(b).  A divisional could nevertheless be properly filed with claims only to invention 2 (the inventorship overlap requirement is met even though at the time of filing divisional, overlap was lost due to deletion (also in MPEP 201.03).

If what you're saying is true, inventorship overlap is completely formalistic and does not necessarily have anything to do with what is ultimately claimed.  In other words, you could always maintain inventorship overlap e.g. in the facts of my original post, by originally filing each continuation with the claims of the parent and then filing preliminary amendments in each case cancelling all those claims and adding new claims, none of the inventors of which are common with those of the originally filed claims. 

Is this correct?

9
Hi,

We have the following situation which I hadn't previously encountered and cannot find a solid answer after much searching:

Application 1 is a nonprovisional with inventors A, B and C.

Application 2 is filed as a continuation of Application 1 (which has since issued as a patent), originally with the same claims as Application 1.  Applicants subsequently filed a preliminary amendment canceling all claims and replacing them with a single new claim.  As a result of the claim cancelations, inventors A, B and C are no longer inventors and were removed by petition.  A new inventor, inventor D, is added as he is the only inventor of the subject matter now claimed in Application 2.

Seems to me the priority claim is no longer valid since, as a result of the amendment, there are no longer any overlapping inventors with Application 1.  The only thing I was able to find in the MPEP is a narrow exception where Application 1 lists inventors A, B and C, but during prosecution a restriction requirement is issued and the Applicant elects an invention of which only inventors B and C are properly listed (inventor A is removed), and a divisional is then filed with invention 2, the inventor of which is only inventor A.  In this case, priority is maintained despite the parent and divisional having no inventors in common as the result of a restriction requirement.  On the other hand, the MPEP does warn that removing inventors may affect the priority claim...

So, my take on this is that the parent application needs to be filed with claims covering all the subject matter in the application.  That way, you are sure to be able to meet the 120 requirements for overlapping inventors for any continuing or divisional application filed off THAT parent application.  However, if, for whatever reason, you file a first divisional/continuation listing only a subset of the inventors originally listed on the parent, you would NOT be able to file a divisional/continuation off the first divisional unless there is at least one inventor in common with those listed on the first divisional (if not, the second divisional would have to be filed directly off the parent).

Any thoughts?

10
NJ Patent1 - assume that the applications are all identical so the provisional is the "first-filed" under the Paris Convention.

It does appear that you can withdraw a PCT prior to the 30 month national stage deadline (MPEP 1859) which would also presumably provide a means for preventing publication of the PCT, although in my hypothetical, neither action is necessary since the requirements of Article 4 Section C (4) apply to the first filed (provisional) application.

However, the ability to withdraw a PCT application prior to publication would become very relevant if the PCT application were the first filed application and you wanted to have a subsequent application considered the first filed.


Thanks

11
Haven't looked at this in a while and I'm a bit rusty.

Say you file a US Provisional application, then file a PCT application with same subject matter 1 year later claiming priority to the provisional.

Is it possible to expressly abandon the PCT prior to publication (assuming it is even possible to expressly abandon a PCT application) and then refile a new PCT application with the same subject matter within one year of the filing date of the original PCT and claim priority to the original PCT?

I would guess that the answer is no due to Article 4, Section C (4) which requires that, in order for a subsequent application (here the 1st PCT) concerning the same subject matter as a previous first application (here the provisional) to be considered the first application for the purpose of Paris Convention priority, that the first application has to (i) have been withdrawn (or abandoned, refused), (ii) not published, and (iii) must not have served as the basis for claiming priority.

In this hypothetical, it seems that it would not be possible to file a 2nd PCT (within one year of filing the 1st PCT) that claims priority to the 1st PCT because the first application (the provisional) already served as the basis for priority of the 1st PCT.

Can anyone confirm?

Thanks

12
Any biotech people in the house?  Appreciate any help in confirming and answering the following:

1. To get a filing date for a nonprovisional, you need only file a specification, claims and drawings if required - it's my understanding that a sequence listing isn't technically considered part of the "specification" and therefore you don't need to file a formal sequence listing to get a filing date.  Rather, you will get a Notice to File Missing Parts requiring that the formal Sequence Listing be filed within a month. 

2. For a continuation or divisional, the sequence listing does not carry over from the parent - you either have to file a new sequence listing or a request that the sequence listing be transferred from the parent to the continuing application

3. You don't have to list sequences in the specification - you can simply refer to them by SEQ ID Number and file a sequence listing with the actual sequences.

So, if you have listed all the sequences in the specification (e.g. in figures) and then file the specification (and claims and drawings) but do not file a sequence listing, you'll get a NOtice to file missing parts and you can file the sequence listing at that point with no issue.

HOWEVER, if you ONLY refer to SEQ ID Nos in the specification and then file the specification (and claims and drawings if necessary) you'll get a Notice to File missing parts but if you try to file the Sequence Listing at that point, that would ahve to be considered new matter, so you'd get a filing date, but would not be able to supplement the application with the sequences and would therefore have to refile (and lose the original filing date).

Can anyone confirm this?

If the above is correct, it would seem to be good practice to include sequences in the specification itself, but this isn't always possible or practical.  I've definitely come across a lot of applications which only contain the actual sequence in teh sequence listing.

Thanks

13
Thanks Jim - I meant that the parent would be available as 102(e) prior art against claims in the CIP not supported by the parent in a 103 rejection, not a 102 rejection.  A 102 rejection would require that the parent describe and enable the claims of the CIP.  There is, of course, on occassion the odd case (e.g. Rasmussen) in which a parent application is held to anticipate a claim to a child application while being unable to support the priority claim due to the divergent treatment of the enablement "utility" requirement for the purposes of priority and anticipation.

In the hypothetical case I refer to below, the parent case describes a small genus and the CIP describes and claims a particular subgenus not explicitly described by the parent.  Inventor D helped reduce the subgenus to practice.

In this case, it would seem we could make the argument that the CIP claims are entitled to the priority of the parent application despite a different inventorship...

14
Background - a first (parent) application was filed with inventors A, B and C who assigned to Corp 1.  While the first application was pending and before it published, a second (CIP) application was filed with inventors A, B, and C who assigned to Corp 1 and inventor D who assigned to Corp 2.

The Examiner issues a nonstatutory double patenting rejection in the second (CIP) application over several claims of the first (parent) application, which I believe can be overcome by having Corp 2 assign the invention to Corp 1 so that the parent and CIP applications are commonly owned and filing a terminal disclaimer.

Now suppose the Examiner issues a 102(e)/103 rejection of the CIP claims over the parent application?  If the claims of the CIP are not supported by the parent application (and the Examiner's rejection is therefore proper), this would seem to be a classic case where the rejection could not be overcome without amending the claims:  the 103(c) exception wouldn't apply because the applications weren't commonly owned at the time of the later invention; declaration under 1.131 cannot be used since the inventive entity of the parent application conceived first, etc.

But suppose we successfully make the argument that the subject matter of the CIP claims is supported by the parent and that we should therefore be entitled to the parent's filing date?  What implications arise from the fact that the parent and CIP applications list a different inventive entity?  Do 102(f) and 102(g) come into play? 

I guess the bottom line is that, although priority under 120 doesn't require identity of inventorship (simply at least one common inventor), I feel like there is something odd about asserting that the claims of a CIP are entitled to the filing date of a parent application listing a different inventive entity...

15
Patent Filing and Prosecution / Terminal disclaimer dilemma
« on: 04-13-11 at 01:57 pm »
Background:  A CIP application has been rejected on the grounds of non-statutory double patenting over the parent application.  The parent application has 3 inventors who have all assigned to corporation A.  The CIP has the same 3 inventors plus another inventor.  The 3 common inventors assigned to corporation A.  The fourth inventor assigned to corporation B.

Problem - we cannot file a terminal disclaimer b/c the applications are not commonly owned.  Is there any reason we cannot have corporation B file an assignment to corporation A and then file a terminal disclaimer?

Does it matter whether the fourth inventor had an obligation to assign to corporation A at the time the invention was made?  I know that this is a requirement under 103(c) (requiring common ownership at the time the later invention was made") but I don't see any similar requirement for filing a terminal disclaimer.

THanks!
 

Pages: [1] 2 3 4 5


Footer

www.intelproplaw.com

Terms of Use
Feel free to contact us:
Sorry, spam is killing us.

iKnight Technologies Inc.

www.intelproplaw.com

Page created in 0.13 seconds with 21 queries.